HEME Home Transfusion Program

NARecruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
LeukemiaMyelomaMyelodysplastic SyndromesHematologic MalignancyHematologic DiseasesLymphoma
Interventions
BEHAVIORAL

HEME-Hospice Program

A care delivery program that combines home-based transfusions with routine home hospice care. Transfusions are administered by trained transfusion nurses. Standard hospice care is provided by an interdisciplinary team of non-transfusion nurse case managers, hospice aides, social workers, and chaplains.

Trial Locations (2)

02215

RECRUITING

Brigham and Women's Hospital, Boston

RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT06487247 - HEME Home Transfusion Program | Biotech Hunter | Biotech Hunter